cse

Algernon Closes First Tranche of its Recently Announced Private Placement Financing

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 14, 2025 (GLOBE…

2 weeks ago

Rocket Doctor Grants RSUs and Stock Options

Vancouver, BC, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor…

3 weeks ago

Algernon Health Announces Private Placement

VANCOUVER, British Columbia, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0)…

3 weeks ago

Rocket Doctor Signs Contracts with Major U.S. Insurers, Expanding Access to Over 7 Million Patients Across California and New York

October 08, 2025 08:00 ET  | Source: Rocket Doctor AI Inc. Rocket Doctor has signed contracts and is in credentialing…

2 months ago

ROCKET DOCTOR AI INC. ANNOUNCES AUTOMATIC CONVERSION OF SPECIAL WARRANTS

Vancouver, British Columbia, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (the “Company” or “Rocket Doctor AI”) (CSE:…

2 months ago

Revive Therapeutics Announces Closing of Second Tranche of Private Placement

TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a…

2 months ago

Spirit Blockchain Capital Reports H1 & Q2 2025 Results, Completes SpiritLinQ, & Advances Institutional Blockchain Strategy

August 29, 2025 20:54 ET  | Source: Spirit Blockchain Capital Inc. Vancouver, BC, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Spirit…

3 months ago

John Kennedy FitzGerald Increases Ownership in Greenhawk Resources Inc. and Announces Leadership Changes

TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Greenhawk Resources Inc. (“Greenhawk” or the "Company") (CSE: GRHK) announces John Kennedy FitzGerald…

4 months ago

Cannabix Technologies Annual General and Special Meeting Results

July 24, 2025 21:06 ET  | Source: Cannabix Technologies Inc. VANCOUVER, British Columbia, July 24, 2025 (GLOBE NEWSWIRE) -- Cannabix…

4 months ago

Revive Therapeutics Clarifies Completion of Key Nerve Agent Countermeasure Study

TORONTO, July 08, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a…

5 months ago